Point72 Asia (Singapore) Pte. Ltd. Vanda Pharmaceuticals Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 63,403 shares of VNDA stock, worth $387,392. This represents 0.07% of its overall portfolio holdings.
Number of Shares
63,403
Previous 5,172
1125.89%
Holding current value
$387,392
Previous $21.8 Million
1093.82%
% of portfolio
0.07%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VNDA
# of Institutions
151Shares Held
49.2MCall Options Held
49.1KPut Options Held
107K-
Black Rock Inc. New York, NY8.14MShares$49.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.28MShares$26.1 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$20.7 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$14.5 Million0.03% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.8MShares$11 Million0.01% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $346M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...